A carregar...
Sodium-glucose cotransporter 2 inhibition: towards an indication to treat diabetic kidney disease
Sodium-glucose cotransporter 2 inhibitors (SGLT2i) have clearly demonstrated their beneficial effect in diabetic kidney disease (DKD) on top of the standard of care [blood glucose control, renin–angiotensin system blockade, smoking cessation and blood pressure (BP) control], even in patients with ov...
Na minha lista:
| Publicado no: | Nephrol Dial Transplant |
|---|---|
| Main Authors: | , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Oxford University Press
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6993197/ https://ncbi.nlm.nih.gov/pubmed/32003834 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ndt/gfz237 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|